 Connection
Charles Dinarello to Renal Dialysis
This is a "connection" page, showing publications Charles Dinarello has written about Renal Dialysis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.964 |
|
|
|
-
Lonnemann G, Bahlmann FH, Freise J, Hertel B, Dinarello CA. Low-flux hemodialysis suppresses interferon-gamma production: the possible role of beta2-microglobulin. Clin Nephrol. 2009 Sep; 72(3):170-6.
Score: 0.255
-
Pereira BJ, Sundaram S, Barrett TW, Butt NK, Porat R, King AJ, Dinarello CA. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood. Clin Nephrol. 1996 Dec; 46(6):394-401.
Score: 0.106
-
Dinarello CA, Roubenoff RA. Mechanisms of loss of lean body mass in patients on chronic dialysis. Blood Purif. 1996; 14(5):388-94.
Score: 0.099
-
Pereira BJ, Dinarello CA. Role of cytokines in patients on dialysis. Int J Artif Organs. 1995 Jun; 18(6):293-304.
Score: 0.095
-
Dinarello CA. Interleukin-1 and interleukin-1 receptor antagonist production during haemodialysis: which cytokine is a surrogate marker for dialysis-related complications? Nephrol Dial Transplant. 1995; 10 Suppl 3:25-8.
Score: 0.092
-
Pereira BJ, King AJ, Falagas ME, Dinarello CA. Interleukin-1 receptor antagonist: an index of dialysis-induced interleukin-1 production. Nephron. 1994; 67(3):358-61.
Score: 0.086
-
Pereira BJ, Dinarello CA. Production of cytokines and cytokine inhibitory proteins in patients on dialysis. Nephrol Dial Transplant. 1994; 9 Suppl 2:60-71.
Score: 0.086
-
Pereira BJ, King AJ, Poutsiaka DD, Strom JA, Dinarello CA. Comparison of first use and reuse of cuprophan membranes on interleukin-1 receptor antagonist and interleukin-1 beta production by blood mononuclear cells. Am J Kidney Dis. 1993 Aug; 22(2):288-95.
Score: 0.084
-
Dinarello CA. Interleukin-1 and tumor necrosis factor and their naturally occurring antagonists during hemodialysis. Kidney Int Suppl. 1992 Oct; 38:S68-77.
Score: 0.079
-
Dinarello CA. Cytokines: agents provocateurs in hemodialysis? Kidney Int. 1992 Mar; 41(3):683-94.
Score: 0.076
-
Dinarello CA. Interleukin-1 and inhibition of interleukin-1 in hemodialysis patients. Contrib Nephrol. 1990; 86:48-69; discussion 69-72.
Score: 0.065
-
Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int. 1990 Jan; 37(1):85-93.
Score: 0.065
-
Lonnemann G, Koch KM, Shaldon S, Dinarello CA. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1. J Lab Clin Med. 1988 Jul; 112(1):76-86.
Score: 0.059
-
Dinarello CA, Koch KM, Shaldon S. Interleukin-1 and its relevance in patients treated with hemodialysis. Kidney Int Suppl. 1988 Mar; 24:S21-6.
Score: 0.058
-
Shaldon S, Koch KM, Dinarello CA. Interleukin-1 activation and acute phase response during hemodialysis. Contrib Nephrol. 1988; 61:18-26.
Score: 0.057
-
Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int. 1988 Jan; 33(1):29-35.
Score: 0.057
-
Dinarello CA. Interleukin-1--its multiple biological effects and its association with hemodialysis. Blood Purif. 1988; 6(3):164-72.
Score: 0.057
-
Shaldon S, Dinarello CA. The relationship between biocompatibility and interleukin-1. Life Support Syst. 1987 Oct-Dec; 5(4):341-5.
Score: 0.056
-
Dinarello CA, Lonnemann G, Bingel M, Koch KM, Shaldon S. Biological consequences of monocyte activation during hemodialysis. Contrib Nephrol. 1987; 59:1-9.
Score: 0.053
-
Lonnemann G, Bingel M, Koch KM, Shaldon S, Dinarello CA. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res. 1987; 6(2):63-70.
Score: 0.053
-
Bingel M, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Human interleukin-1 production during hemodialysis. Nephron. 1986; 43(3):161-3.
Score: 0.050
-
Pearson FC, Bohon J, Lee W, Bruszer G, Sagona M, Dawe R, Jakubowski G, Morrison D, Dinarello C. Comparison of chemical analyses of hollow-fiber dialyzer extracts. Artif Organs. 1984 Aug; 8(3):291-8.
Score: 0.045
-
Dinarello CA. Pathogenesis of fever during hemodialysis. Contrib Nephrol. 1983; 36:90-9.
Score: 0.040
-
Jaber BL, Gonski JA, Cendoroglo M, Balakrishnan VS, Razeghi P, Dinarello CA, Pereira BJ. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate. Blood Purif. 1998; 16(4):210-9.
Score: 0.028
-
Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int. 1994 Mar; 45(3):890-6.
Score: 0.022
-
Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, Koch KM. Gene expression of interleukin-1 beta during hemodialysis. Kidney Int. 1993 Mar; 43(3):712-21.
Score: 0.020
-
Pereira BJ, Poutsiaka DD, King AJ, Strom JA, Narayan G, Levey AS, Dinarello CA. In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD. Kidney Int. 1992 Dec; 42(6):1419-24.
Score: 0.020
-
Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Induction of interleukin-1 and tumor necrosis factor during in vitro hemodialysis with different membranes. Contrib Nephrol. 1989; 74:58-65.
Score: 0.015
-
Shaldon S, Dinarello C, Port F, Kluger M. Interleukin-1: the pros and cons of its clinical relevance. Artif Organs. 1988 Jun; 12(3):221.
Score: 0.015
-
Shaldon S, Dinarello CA, Koch KM, Lonnemann G, Bingel M, Granolleras C, Deschodt G, Branger B, Oul?s R, Fourcade J. Interleukin-1 and dialysis. Adv Nephrol Necker Hosp. 1988; 17:423-34.
Score: 0.014
-
Bingel M, Lonnemann G, Koch KM, Dinarello CA, Shaldon S. Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranes. Nephron. 1988; 50(4):273-6.
Score: 0.014
-
Shaldon S, Dinarello C, Elie M, Koch KM. Interleukin-1 and biocompatibility in haemodialysis. Contrib Nephrol. 1988; 62:128-31.
Score: 0.014
-
Shaldon S, Elie M, Koch KM, Dinarello CA. Interleukin-1 stimulation in the ESRD patient: potential long-term consequences. Transplant Proc. 1987 Oct; 19(5):4353-7.
Score: 0.014
-
Dinarello CA, Lonnemann G, Maxwell R, Shaldon S. Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial cultures. J Clin Microbiol. 1987 Jul; 25(7):1233-8.
Score: 0.014
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|